Donald Lombardi, MS
Co-Director, Pediatric Device Clinical Evaluation Core
Donald Lombardi is founder and Chief Executive Officer of the Institute for Pediatric Innovation (IPI), a collaborative nonprofit organization dedicated to addressing unmet medical product needs in pediatric care. Under Mr. Lombardi’s leadership, IPI has formed partnerships with key leaders in the pharmaceutical industry, hospitals, universities, and pediatric advocacy leaders to create medical devices and drugs specifically for children. Mr. Lombardi uses his experience in higher education, intellectual property, and biomedical business to overcome the barriers to making medical innovations commercially available for treating children. His experience in pediatric medical product commercialization spans 15 years as Chief Intellectual Property Officer of Boston Children’s Hospital plus seven years as CEO of IPI. Mr. Lombardi is also Coordinator of the Global Alliance for Pediatric Therapeutics, a pharmaceutical industry collaboration to develop best practices for pediatric drug development. He consults on intellectual property strategy and management for healthcare and research organizations worldwide, and is Adjunct Assistant Professor of Pediatrics at Tufts University School of Medicine. He earned an MS in Life Sciences from MIT and a BA in Biophysics from Amherst College.